| Dr Aric J Aldridge, MD | |
|
1450 Ross Clark Cir Ste 100, Dothan, AL 36301-4770 | |
| (334) 479-0043 | |
| (334) 479-0048 |
| Full Name | Dr Aric J Aldridge |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 24 Years |
| Location | 1450 Ross Clark Cir Ste 100, Dothan, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194770511 | NPI | - | NPPES |
| 171028458A | Medicaid | GA | |
| 054537 | Other | GA | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 054537 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital And Manor | Bainbridge, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mckinley, P.c. | 2264615467 | 2 |
| Mckinley, P.c. | 2264615467 | 2 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects approximately 15% of the population in the industrialized world.
Management Sciences for Health (MSH), a Massachusetts-based global health nonprofit organization, today announced it is mobilizing its expertise and resources at the epicenter of the Ebola epidemic in Liberia to help the Ministry of Health develop community care centers for Ebola separate from the health facilities; restore essential health services for non-Ebola patients; and, improve the detection and containment of active Ebola cases in Liberian communities.
Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that GSK has initiated its second pivotal Phase 3 trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with acute coronary syndrome (ACS).
Scientists at the national scientific research center at the University of Paris in France, discovered the link between trans-fats and breast cancer after carrying out a study of women taking part in a large European cancer trial.
The problem currently affects around 15 per cent of the adult population and rising, as people retain their teeth for longer. The most common cause is receding gums, resulting from teeth grinding, abrasion or tooth decay, which exposes the dentine.
› Verified 5 days ago
| Entity Name | Mckinley, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235436510 PECOS PAC ID: 2264615467 Enrollment ID: O20200908001432 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects approximately 15% of the population in the industrialized world.
Management Sciences for Health (MSH), a Massachusetts-based global health nonprofit organization, today announced it is mobilizing its expertise and resources at the epicenter of the Ebola epidemic in Liberia to help the Ministry of Health develop community care centers for Ebola separate from the health facilities; restore essential health services for non-Ebola patients; and, improve the detection and containment of active Ebola cases in Liberian communities.
Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that GSK has initiated its second pivotal Phase 3 trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with acute coronary syndrome (ACS).
Scientists at the national scientific research center at the University of Paris in France, discovered the link between trans-fats and breast cancer after carrying out a study of women taking part in a large European cancer trial.
The problem currently affects around 15 per cent of the adult population and rising, as people retain their teeth for longer. The most common cause is receding gums, resulting from teeth grinding, abrasion or tooth decay, which exposes the dentine.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aric J Aldridge, MD 1450 Ross Clark Cir Ste 100, Dothan, AL 36301-4770 Ph: (334) 479-0043 | Dr Aric J Aldridge, MD 1450 Ross Clark Cir Ste 100, Dothan, AL 36301-4770 Ph: (334) 479-0043 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects approximately 15% of the population in the industrialized world.
Management Sciences for Health (MSH), a Massachusetts-based global health nonprofit organization, today announced it is mobilizing its expertise and resources at the epicenter of the Ebola epidemic in Liberia to help the Ministry of Health develop community care centers for Ebola separate from the health facilities; restore essential health services for non-Ebola patients; and, improve the detection and containment of active Ebola cases in Liberian communities.
Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that GSK has initiated its second pivotal Phase 3 trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with acute coronary syndrome (ACS).
Scientists at the national scientific research center at the University of Paris in France, discovered the link between trans-fats and breast cancer after carrying out a study of women taking part in a large European cancer trial.
The problem currently affects around 15 per cent of the adult population and rising, as people retain their teeth for longer. The most common cause is receding gums, resulting from teeth grinding, abrasion or tooth decay, which exposes the dentine.
› Verified 5 days ago
Mr. Jean Guy Fortin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2800 Ross Clark Circle, Dothan, AL 36301 Phone: 334-793-2211 Fax: 334-793-7161 | |
Dr. Ronald P. Swendris, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2800 Ross Clark Cir, Dothan, AL 36301 Phone: 334-793-2211 Fax: 334-793-7161 | |
Dr. Harsha A. Sen, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2800 Ross Clark Cir, Dothan, AL 36301 Phone: 334-793-2211 Fax: 334-793-7161 | |
William Timothy Gannon, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2664 Hartford Hwy, Dothan, AL 36305 Phone: 334-699-2244 Fax: 334-699-2245 | |
Dr. Jorge L Arango, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 160 Healthwest Dr, Dothan, AL 36303 Phone: 334-793-2211 Fax: 334-793-7161 | |
Dr. Andrew F Dannemann, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1909 Honeysuckle Rd, Suite 2, Dothan, AL 36305 Phone: 334-699-7100 Fax: 334-699-7410 |